Uncommon buccolingual masticatory syndrome: Antipsychotic medicine not only allows you to live a normal life, but it also increases the risk of physical changes

Abstract

Background and aims: Bucco-lingual masticatory syndrome is an uncontrollable movement of the mouth, tongue, lips, face, and cheeks that is associated with first-generation antipsychotic drugs. This case study depicts the onset of a bucco-lingual masticatory syndrome caused by haloperidol in an adult patient. Case Presentation: On August 2, 2022, a patient in their 40s who had been experiencing bucco-lingual masticatory syndrome for two days was brought into the emergency room. The patient had already been treated with haloperidol for schizophreniform illness two years prior. A two-day history of backward orofacial movement, chewing and masticatory difficulties, an inability to talk, and exhaustion was given by the patient. The patient's blood samples showed that the results of the tests for his complete blood count, blood sugar, lipid profile, renal function, and liver function done on the first two days after admission were within normal ranges. The trihexyphenidyl hydrochloride oral dosage of 5 mg was started as soon as the patient was admitted, and within 24 hours, the patient's backward orofacial movement was restored to normal. Conclusions: The side effects of first-generation antipsychotic medications are entirely controllable and can be avoided by switching to a different medication, administering an antidote, or lowering the dosage.